跳至主要内容
临床试验/ISRCTN45751386
ISRCTN45751386已完成未知

Randomized trial of treatment and follow-up of vaginal intraepithelial neoplasia (VAIN)

Helsinki University Central Hospital (Finland)0 个研究点目标入组 30 人开始时间: 2013年4月15日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. A biopsy-confirmed VAIN1 that has persisted for two years or biopsy-confirmed VAIN2-3
  • 2. Previously laser or surgically treated VAIN, when previous treatment has occurred over 1 month prior
  • 3. Immune compromised patients (i.e. patients with rheumatoid arthritis, scleroderma, etc.) who frequently have VAIN
  • 4. Patients of legal age (18 years old and above)

排除标准

  • 1. Vaginal carcinoma
  • 2. Pregnancy or breast-feeding
  • 3. Lack of reliable contraception in premenopausal patients
  • 4. Known allergy to imiquimod
  • 5. Language difficulties (patients who do not speak sufficient Finnish or English)
  • 6. Simultaneous need for Loop Electrosurgical Excision Procedure (LEEP)
  • 7. HIV positive

研究者

发起方
Helsinki University Central Hospital (Finland)

相似试验